Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
Titel:
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
Auteur:
Erber, Ramona Gluz, Oleg Brünner, Nils Kreipe, Hans Heinrich Pelz, Enrico Kates, Ronald Bartels, Annette Huober, Jens Mohrmann, Svjetlana Moustafa, Zehra Liedtke, Cornelia Möbus, Volker Augustin, Doris Thomssen, Christoph Jänicke, Fritz Kiechle, Marion Kuhn, Walther Nitz, Ulrike Harbeck, Nadia Hartmann, Arndt